EARNEST Partners’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q4 | – | Sell |
-456
| Closed | -$34.2K | – | 612 |
|
2023
Q3 | $34.2K | Hold |
456
| – | – | ﹤0.01% | 409 |
|
2023
Q2 | $35.1K | Hold |
456
| – | – | ﹤0.01% | 387 |
|
2023
Q1 | $37.8K | Hold |
456
| – | – | ﹤0.01% | 372 |
|
2022
Q4 | $39.1K | Hold |
456
| – | – | ﹤0.01% | 369 |
|
2022
Q3 | $28K | Hold |
456
| – | – | ﹤0.01% | 393 |
|
2022
Q2 | $28K | Hold |
456
| – | – | ﹤0.01% | 402 |
|
2022
Q1 | $27K | Hold |
456
| – | – | ﹤0.01% | 427 |
|
2021
Q4 | $33K | Sell |
456
-175
| -28% | -$12.7K | ﹤0.01% | 398 |
|
2021
Q3 | $44K | Hold |
631
| – | – | ﹤0.01% | 351 |
|
2021
Q2 | $43K | Hold |
631
| – | – | ﹤0.01% | 357 |
|
2021
Q1 | $41K | Hold |
631
| – | – | ﹤0.01% | 356 |
|
2020
Q4 | $37K | Hold |
631
| – | – | ﹤0.01% | 355 |
|
2020
Q3 | $40K | Hold |
631
| – | – | ﹤0.01% | 327 |
|
2020
Q2 | $49K | Hold |
631
| – | – | ﹤0.01% | 307 |
|
2020
Q1 | $47K | Hold |
631
| – | – | ﹤0.01% | 300 |
|
2019
Q4 | $41K | Hold |
631
| – | – | ﹤0.01% | 336 |
|
2019
Q3 | $40K | Hold |
631
| – | – | ﹤0.01% | 332 |
|
2019
Q2 | $43K | Hold |
631
| – | – | ﹤0.01% | 335 |
|
2019
Q1 | $41K | Hold |
631
| – | – | ﹤0.01% | 333 |
|
2018
Q4 | $39K | Hold |
631
| – | – | ﹤0.01% | 329 |
|
2018
Q3 | $49K | Hold |
631
| – | – | ﹤0.01% | 320 |
|
2018
Q2 | $45K | Hold |
631
| – | – | ﹤0.01% | 326 |
|
2018
Q1 | $48K | Hold |
631
| – | – | ﹤0.01% | 315 |
|
2017
Q4 | $45K | Buy |
+631
| New | +$45K | ﹤0.01% | 310 |
|
2017
Q1 | – | Sell |
-631
| Closed | -$45K | – | 496 |
|
2016
Q4 | $45K | Buy |
+631
| New | +$45K | ﹤0.01% | 292 |
|